Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian L Strom

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
JAMA|December 2, 2004
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: a counterpointBrian L Strom
JAMA|May 4, 2006
How the US drug safety system should be changedBrian L Strom
Medical Care|October 25, 2007
Methodologic challenges to studying patient safety and comparative effectivenessBrian L Strom
The New England Journal of Medicine|April 9, 2005
Statins and over-the-counter availabilityBrian L Strom
Pharmacoepidemiology and Drug Safety|March 20, 2003
Toward improved adverse event/suspected adverse drug reaction reportingRobert Gross, Brian L Strom
Journal of Clinical Epidemiology|July 13, 2004
Participants and refusers in a telephone interview about hormone replacement therapy were equally likely to be taking itBrian L Strom, Rita Schinnar
Journal of Clinical Epidemiology|November 30, 2004
An interview strategy was critical for obtaining valid information on the use of hormone replacement therapyBrian L Strom, Rita Schinnar
LDI Issue Brief|March 4, 2011
Evaluating health information technology's clinical effectsBrian L Strom, Rita Schinnar,
Annual Review of Pharmacology and Toxicology|October 9, 2014
Improving postapproval drug safety surveillance: getting better information soonerSean Hennessy, Brian L Strom
LDI Issue Brief|October 28, 2003
The ineffectiveness of retrospective drug utilization reviewSean Hennessy, Brian L Strom
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
JAMA|December 2, 2004
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: a counterpointBrian L Strom
JAMA|May 4, 2006
How the US drug safety system should be changedBrian L Strom
Medical Care|October 25, 2007
Methodologic challenges to studying patient safety and comparative effectivenessBrian L Strom
The New England Journal of Medicine|April 9, 2005
Statins and over-the-counter availabilityBrian L Strom
Pharmacoepidemiology and Drug Safety|March 20, 2003
Toward improved adverse event/suspected adverse drug reaction reportingRobert Gross, Brian L Strom
Journal of Clinical Epidemiology|July 13, 2004
Participants and refusers in a telephone interview about hormone replacement therapy were equally likely to be taking itBrian L Strom, Rita Schinnar
Journal of Clinical Epidemiology|November 30, 2004
An interview strategy was critical for obtaining valid information on the use of hormone replacement therapyBrian L Strom, Rita Schinnar
LDI Issue Brief|March 4, 2011
Evaluating health information technology's clinical effectsBrian L Strom, Rita Schinnar,
Annual Review of Pharmacology and Toxicology|October 9, 2014
Improving postapproval drug safety surveillance: getting better information soonerSean Hennessy, Brian L Strom
LDI Issue Brief|October 28, 2003
The ineffectiveness of retrospective drug utilization reviewSean Hennessy, Brian L Strom
Pageof 25